Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how survival rates for brain cancer in the United Kingdom compare with those of other countries of equivalent wealth.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Reducing the number of lives lost to cancer is a key aim of the National Cancer Plan for England, which will be published later this year. The plan will include further details on how the Government will improve outcomes for cancer patients, including brain cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates.
The Department is committed to working closely with partners and patient groups to shape the long-term vision for cancer. On 4 February 2025, the Department launched a call for evidence for the National Cancer Plan which closed on 29 April. We have received over 11,000 responses from individuals, professionals, and organisations who have shared their views on how we can do more to achieve our ambition, including several brain cancer charities. The call for evidence gave an opportunity to all partners to shape the National Cancer Plan. These submissions are being used to inform our plan to improve cancer care.
The Department recognises that cancer patients, including those with brain tumours, are often waiting too long for referral and treatment. As the first step to ensuring early diagnosis and treatment, NHS England has delivered an extra 40,000 operations, scans, and appointments each week since the start of this administration.
The Department is supporting NHS England in implementing genomic testing, including whole genome sequencing (WGS), in the National Health Service, provided through the NHS Genomic Medicine Service, and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the National Genomic Test Directory, which includes tests for over 200 cancer clinical indications, including WGS tests for a range of brain tumours. The NHS now offers all children and young people with cancer, and adults with certain cancers including brain cancer, whole genome sequencing to enable more comprehensive and precise diagnosis, and access to more personalised treatments.
The Department recognises that there are currently limited treatment options available for people who have been diagnosed with brain tumours, and the significant impact that rarer forms of cancer can have on patients, carers, and their families. A new national Brain Tumour Research Consortium was established in December 2024 to bring together researchers from a range of different disciplines and institutions with the aim of driving scientific advancements in how to prevent, detect, manage, and treat cancers in adults and children. The work being undertaken by the consortium aims to ensure that patients have access to the latest treatments and technology and to clinical trials. This will make a significant contribution to bringing the United Kingdom’s cancer survival rates back up to the standards of the best in the world. The following table shows brain cancer five-year survival percentages for adults, those aged 15 to 99 years old, diagnosed from 2010 to 2014, by G7 country:
Country | Cancer site | Five-year net survival |
Japan | Brain (adults) | 46.3% |
USA | Brain (adults) | 36.5% |
Canada | Brain (adults) | 29.9% |
Germany | Brain (adults) | 29.6% |
Italy | Brain (adults) | 28.8% |
France | Brain (adults) | 27.2% |
UK | Brain (adults) | 26.3% |
Source: CONCORD-3, CONCORD Programme, London School of Hygiene and Tropical Medicine.
This data will be updated with the publication of CONCORD-4, which is currently in progress.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to meet Brain Cancer Justice.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Reducing the number of lives lost to cancer is a key aim of the National Cancer Plan for England, which will be published later this year. The plan will include further details on how the Government will improve outcomes for cancer patients, including brain cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates.
The Department is committed to working closely with partners and patient groups to shape the long-term vision for cancer. On 4 February 2025, the Department launched a call for evidence for the National Cancer Plan which closed on 29 April. We have received over 11,000 responses from individuals, professionals, and organisations who have shared their views on how we can do more to achieve our ambition, including several brain cancer charities. The call for evidence gave an opportunity to all partners to shape the National Cancer Plan. These submissions are being used to inform our plan to improve cancer care.
The Department recognises that cancer patients, including those with brain tumours, are often waiting too long for referral and treatment. As the first step to ensuring early diagnosis and treatment, NHS England has delivered an extra 40,000 operations, scans, and appointments each week since the start of this administration.
The Department is supporting NHS England in implementing genomic testing, including whole genome sequencing (WGS), in the National Health Service, provided through the NHS Genomic Medicine Service, and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the National Genomic Test Directory, which includes tests for over 200 cancer clinical indications, including WGS tests for a range of brain tumours. The NHS now offers all children and young people with cancer, and adults with certain cancers including brain cancer, whole genome sequencing to enable more comprehensive and precise diagnosis, and access to more personalised treatments.
The Department recognises that there are currently limited treatment options available for people who have been diagnosed with brain tumours, and the significant impact that rarer forms of cancer can have on patients, carers, and their families. A new national Brain Tumour Research Consortium was established in December 2024 to bring together researchers from a range of different disciplines and institutions with the aim of driving scientific advancements in how to prevent, detect, manage, and treat cancers in adults and children. The work being undertaken by the consortium aims to ensure that patients have access to the latest treatments and technology and to clinical trials. This will make a significant contribution to bringing the United Kingdom’s cancer survival rates back up to the standards of the best in the world. The following table shows brain cancer five-year survival percentages for adults, those aged 15 to 99 years old, diagnosed from 2010 to 2014, by G7 country:
Country | Cancer site | Five-year net survival |
Japan | Brain (adults) | 46.3% |
USA | Brain (adults) | 36.5% |
Canada | Brain (adults) | 29.9% |
Germany | Brain (adults) | 29.6% |
Italy | Brain (adults) | 28.8% |
France | Brain (adults) | 27.2% |
UK | Brain (adults) | 26.3% |
Source: CONCORD-3, CONCORD Programme, London School of Hygiene and Tropical Medicine.
This data will be updated with the publication of CONCORD-4, which is currently in progress.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to improve survival rates from brain cancers.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Reducing the number of lives lost to cancer is a key aim of the National Cancer Plan for England, which will be published later this year. The plan will include further details on how the Government will improve outcomes for cancer patients, including brain cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates.
The Department is committed to working closely with partners and patient groups to shape the long-term vision for cancer. On 4 February 2025, the Department launched a call for evidence for the National Cancer Plan which closed on 29 April. We have received over 11,000 responses from individuals, professionals, and organisations who have shared their views on how we can do more to achieve our ambition, including several brain cancer charities. The call for evidence gave an opportunity to all partners to shape the National Cancer Plan. These submissions are being used to inform our plan to improve cancer care.
The Department recognises that cancer patients, including those with brain tumours, are often waiting too long for referral and treatment. As the first step to ensuring early diagnosis and treatment, NHS England has delivered an extra 40,000 operations, scans, and appointments each week since the start of this administration.
The Department is supporting NHS England in implementing genomic testing, including whole genome sequencing (WGS), in the National Health Service, provided through the NHS Genomic Medicine Service, and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the National Genomic Test Directory, which includes tests for over 200 cancer clinical indications, including WGS tests for a range of brain tumours. The NHS now offers all children and young people with cancer, and adults with certain cancers including brain cancer, whole genome sequencing to enable more comprehensive and precise diagnosis, and access to more personalised treatments.
The Department recognises that there are currently limited treatment options available for people who have been diagnosed with brain tumours, and the significant impact that rarer forms of cancer can have on patients, carers, and their families. A new national Brain Tumour Research Consortium was established in December 2024 to bring together researchers from a range of different disciplines and institutions with the aim of driving scientific advancements in how to prevent, detect, manage, and treat cancers in adults and children. The work being undertaken by the consortium aims to ensure that patients have access to the latest treatments and technology and to clinical trials. This will make a significant contribution to bringing the United Kingdom’s cancer survival rates back up to the standards of the best in the world. The following table shows brain cancer five-year survival percentages for adults, those aged 15 to 99 years old, diagnosed from 2010 to 2014, by G7 country:
Country | Cancer site | Five-year net survival |
Japan | Brain (adults) | 46.3% |
USA | Brain (adults) | 36.5% |
Canada | Brain (adults) | 29.9% |
Germany | Brain (adults) | 29.6% |
Italy | Brain (adults) | 28.8% |
France | Brain (adults) | 27.2% |
UK | Brain (adults) | 26.3% |
Source: CONCORD-3, CONCORD Programme, London School of Hygiene and Tropical Medicine.
This data will be updated with the publication of CONCORD-4, which is currently in progress.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the proposed World Health Organization resolution to make traumatic brain injury a notifiable and chronic condition worldwide and whether they have any plans to support the resolution at the 79th World Health Assembly.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Formal notification and negotiation of proposed resolutions at the World Health Organization (WHO) typically begin in the autumn, including any potential resolution on making traumatic brain injury a notifiable and chronic condition. The United Kingdom gives due consideration to all proposed WHO resolutions and will engage in all resolution negotiations ahead of any adoption at the World Health Assembly, which takes place in May each year. All resolutions to be considered by the World Health Assembly would also be subject to the WHO's budget allocation process.
The UK is committed to addressing traumatic brain injury and we intend to develop an Acquired Brain Injury (ABI) Action or Delivery Plan, with input from NHS England and other Government departments, to be published in the autumn of this year. The forthcoming 10-Year Health Plan will provide the overarching plan for the future of the National Health Service, and a subsequent ABI Plan would then focus on specific actions and deliverables for ABI against the backdrop of the 10-Year Health Plan. This will ensure a coherent, targeted approach. The new ABI Action Plan will be concise, action-oriented, and accountable, in order to drive real change for people with ABI.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government how they are working with international partners to provide support for the population in Myanmar affected by the earthquake.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
On 29 March the UK announced up to £10 million worth of life saving support to Myanmar in response to the earthquake. As well as delivering the humanitarian assistance via local partners, the package includes support in conjunction with other international partners to the United Nations Central Emergency Response Fund (CERF). This will fund life-saving support to some of the most urgent humanitarian needs. On 4 April, we announced a further £10 million of funding, bringing our total response to up to £25 million.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what response they are making to the appeal to the international community regarding the Myanmar earthquake by the Interim National Unity Government of the Republic of the Union of Myanmar.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
On 29 March the UK announced up to £10 million worth of life saving support to Myanmar in response to the earthquake. As well as delivering the humanitarian assistance via local partners, the package includes support in conjunction with other international partners to the United Nations Central Emergency Response Fund (CERF). This will fund life-saving support to some of the most urgent humanitarian needs. On 4 April, we announced a further £10 million of funding, bringing our total response to up to £25 million.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what assessment they have made of reports that the military junta in Myanmar is attacking civilians and others in areas damaged by the earthquake.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
We are aware of recent reports of the Myanmar military conducting airstrikes in the aftermath of the earthquake and are actively investigating this with partners. Since the 2021 coup, we have consistently condemned airstrikes. On 2 April, the Myanmar military announced a temporary ceasefire until 22 April, which we welcome, as we do all other recent ceasefires. We now call on the Myanmar military, and all other parties to the conflict, to fully respect the ceasefires and allow full, safe and unhindered humanitarian access.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what action they are taking to help ensure that their aid reaches those affected by the earthquake in Myanmar.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
On 30th March, we announced up to £10 million of UK support to respond to the devastating earthquake in Myanmar. Our support will be channelled through long-standing local partners, who are able to operate across the earthquake-affected area. On 3rd April, we also announced our support to the Disaster Emergency Committee's efforts to do more for people in desperate need in Myanmar. We are matching public donations pound-for-pound up to £5 million, meaning the public's support will go even further. On 4 April, we announced a further £10 million of funding, bringing our total response to up to £25 million.
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what assessment they have made of how UK aid and volunteers can provide further help to the population of Myanmar affected by the earthquake.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
On 3 April, the Disaster Emergency Committee (DEC) launched a public appeal for the Myanmar earthquake. The DEC brings together 15 leading UK-based aid charities to coordinate public appeals under one banner. The UK Government are providing match funding pound-for-pound up to £5 million. We encourage all those who want to get involved to visit: https://www.dec.org.uk/appeal/myanmar-earthquake-appeal
Asked by: Lord Crisp (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what was the cost in NHS and social services staff time and resources in administering NHS Continuing Healthcare, and undertaking the necessary patient assessments, in each of the past two financial years.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
The Department does not collect data on the cost of administering NHS Continuing Healthcare (CHC) or undertaking CHC assessments.